Correction to: Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells, by Xu et al. Hum Gene Ther 2019;30(4):497–510. DOI: 10.1089/hum.2018.119

In The April 2019 issue of Human Gene Therapy (vol. 30, no. 4; pp. 497–510) the article entitled “Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells” requires correction. In Figure 4A, the western blot image for SAHA-treated Daudi cells was a duplicate of Romidespin-treated Raji cells. A revised figure has been supplied with the correct blots.

Original Figure 4 A:

Updated Figure 4A:

The online version of the article has been corrected to reflect this. The authors apologize for this honest error.